The U.S. Food and Drug Administration has approved Amgen and AstraZeneca's drug for a type of chronic inflammatory sinus ...
The 2025 Lord Mayor’s Business Awards shine a spotlight on this community of visionaries and game-changers driving Brisbane – ...
Just days after gaining similar regulatory approval in the USA, AstraZeneca and Amgen’s Tezspire (tezepelumab) has been ...
Lab-grown seafood, a new treatment for Parkinson's disease and a kid-safe power saw are among the genius ideas from UC ...
A copy of the Company’s presentation will be available under the Presentations tab of the Tonix website at https://ir.tonixpharma.com/presentations.
US FDA approves expanded paediatric indications for Celltrion’s Yuflyma and unbranded adalimumab-aaty: Incheon, South Korea Monday, October 20, 2025, 17:00 Hrs [IST] Celltrion, ...
Approval Broadens Indication for TEZSPIRE to a Second Disease Characterized by Epithelial-Driven Inflammation THOUSAND OAKS, Calif., Oct. 17, 2025 ...
YUFLYMA® (adalimumab-aaty), and its unbranded version, are now approved for two additional pediatric indications - adolescent hidradenitis suppurativa (HS) and pediatric uveitis (UV), in the ...
Approval Broadens Indication for TEZSPIRE to a Second Disease Characterized by Epithelial-Driven Inflammation THOUSAND OAKS, Calif., Oct. 17, 2025 /PRNewswire/ -- ...
The best room humidifier can offer comfortably moisturized air in the dry winter months. These 10 models are our go-to picks ...
The newly constructed G D Naidu Flyover on Avinashi Road will soon be equipped with AI-based cameras. These cameras are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback